Open Orphan chief to underwrite part of £30m hVivo takeover

Friel ready to stump up €3m of fundraising for purchase of British clinical trials firm

15th December, 2019
Open Orphan chief to underwrite part of £30m hVivo takeover
Open Orphan chief executive Cathal Friel: his underwriting will only kick in if the company fails to raise the cash from external investors

Open Orphan chief executive Cathal Friel will underwrite about €3 million of the company’s planned fundraising as part of its £30 million takeover of British company hVivo.

Pharma services company Open Orphan is to launch a share placing early in the new year to raise as much as £10 million from investors to fund the takeover of the British company, which is involved in clinical trials. Friel is one of the largest investors...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Chanelle founder invests €100k in Redesdale Group

Malin shareholders in line for windfall after €119 million cash boost

Amryt seeks to have rare condition drug approved for payment

Icon to restore staff pay as business recovers from virus